Effectiveness of the tetrapeptide HAEE: an innovative approach to Alzheimer's treatment in experimentation
Introduction: Alzheimer’s disease (AD) is the most common neurodegenerative disorder, characterized by a progressive decline in cognitive functions. According to the “Alzheimer’s Disease International”, there were 36 million reported cases of AD worldwide in 2009, with projections suggesting an incr...
Saved in:
Main Author: | Evgenii A. Patrakhanov |
---|---|
Format: | Article |
Language: | English |
Published: |
Belgorod National Research University
2024-12-01
|
Series: | Research Results in Pharmacology |
Subjects: | |
Online Access: | https://rrpharmacology.ru/index.php/journal/article/view/548 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted Magnetic Nanoparticles for Beta-Amyloid Detection
by: Nelly S. Chmelyuk, et al.
Published: (2024-10-01) -
Substance P- and Insulin-like Growth Factor 1-derived Tetrapeptides for Neurotrophic Keratopathy Related to Leprosy: A Clinical Trial
by: Shoko Kondo, MD, et al.
Published: (2025-03-01) -
A promising drug repurposing approach for Alzheimer's treatment: Givinostat improves cognitive behavior and pathological features in APP/PS1 mice
by: Qi-Chao Gao, et al.
Published: (2024-12-01) -
Diagnosis and Treatment of Alzheimer’s Disease: Current Update
by: Younghee Yim, et al.
Published: (2025-01-01) -
The effectiveness of music therapy for the treatment of Alzheimer's disease
by: Dominka Rehan, et al.
Published: (2024-12-01)